Unknown

Dataset Information

Methylprednisolone alone or combined with cyclosporine or mycophenolate mofetil for the treatment of immune-mediated hemolytic anemia in dogs, a prospective study.


ABSTRACT:

Background

Benefit of adding a second-line immunosuppressive drug to glucocorticoids for the treatment of non-associative immune-mediated hemolytic anemia (naIMHA) in dogs has not been defined prospectively.

Hypothesis/objectives

Evaluate the effectiveness of different immunosuppressive protocols in naIMHA dogs.

Animals

Forty-three client-owned dogs.

Methods

Open label, randomized, clinical trial. Dogs were treated with methylprednisolone (M-group), methylprednisolone plus cyclosporine (MC-group) or methylprednisolone plus mycophenolate mofetil (MM-group). Dogs were defined as responders by disappearance of signs of immune-mediated destruction and hematocrit stabilization. Frequency of responders was compared between M-group and combined protocols (MC and MM-gr

SUBMITTER: Agnoli C 

PROVIDER: S-EPMC11423485 | biostudies-literature | 2024 Sep-Oct

REPOSITORIES: biostudies-literature